Literature DB >> 4931454

Histocompatibility genes of mice. XI. Evidence establishing a new histocompatibility locus, H-12, and new H-2 allele, H-2bc.

G D Snell, R J Graff, M Cherry.   

Abstract

Entities:  

Mesh:

Year:  1971        PMID: 4931454

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  7 in total

1.  Susceptibility of allogeneic mice to teratocarcinoma 402AX.

Authors:  S Ostrand-Rosenberg; T M Rider; A Twarowski
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

2.  Species-specific class I gene expansions formed the telomeric 1 mb of the mouse major histocompatibility complex.

Authors:  Toyoyuki Takada; Attila Kumánovics; Claire Amadou; Masayasu Yoshino; Elsy P Jones; Maria Athanasiou; Glen A Evans; Kirsten Fischer Lindahl
Journal:  Genome Res       Date:  2003-04       Impact factor: 9.043

3.  Absence of H-2 antigens capable of reacting with cytotoxic T cells on a teratoma line expressing a T/t locus antigen.

Authors:  J Forman; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

4.  The genetics of teratocarcinoma transplantation: tumor formation in allogeneic hosts by the embryonal carcinoma cell lines F9 and PCC3.

Authors:  P R Avner; W F Dove; P Dubois; J A Gaillard; J L Guénet; F Jacob; H Jakob; A Shedlovsky
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

5.  Autosomal phosphoglycerate kinase linked to mouse major histocompatibility complex.

Authors:  E M Eicher; M Cherry; L Flaherty
Journal:  Mol Gen Genet       Date:  1978-01-17

6.  Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts.

Authors:  K Illmensee; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

7.  Comparative immunogenicity and enhanceability of individual H-2K and H-2D specificities of the murine histocompatibility-2 complex.

Authors:  I F McKenzie; G D Snell
Journal:  J Exp Med       Date:  1973-07-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.